News-Medical.Net August 22, 2024
In a recent study published in Nature Medicine, researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson’s disease (PD).
Current treatment options for PD
PD is a neurological disease that affects millions of people 60 years and older, many of whom reside in high-income nations. PD treatment often includes levodopa, a medication that replaces dopamine-producing neurons in deep brain areas that are important for movement control. However, excess dopamine can lead to dyskinesia, uncontrollable movements, tremors, and stiffness, which may limit the efficacy of this treatment in some patients.
As a result, some PD patients are treated with continuous DBS (cDBS) devices, which deliver continuous electrical stimulation to...
Today's Sponsors
Today's Sponsor